Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewsWire • 06/05/24
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual MeetingGlobeNewsWire • 05/28/24
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/09/24
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024GlobeNewsWire • 05/08/24
Polarean Imaging to showcase Xenon MRI at Respiratory Innovation SummitProactive Investors • 05/08/24
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceGlobeNewsWire • 05/07/24
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate UpdateGlobeNewsWire • 05/02/24
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual MeetingGlobeNewsWire • 04/16/24
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceGlobeNewsWire • 04/10/24
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/04/24
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024GlobeNewsWire • 03/05/24
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/29/24
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate UpdateGlobeNewsWire • 02/22/24
Wall Street Analysts Think Xenon Pharmaceuticals (XENE) Could Surge 25.76%: Read This Before Placing a BetZacks Investment Research • 01/19/24
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/24